COMMUNIQUÉS West-GlobeNewswire

Marche de sensibilisation à l’autisme
26/04/2019
MONTRÉAL, 26 avr. 2019 (GLOBE NEWSWIRE) -- Samedi le 27 avril 2019, prendra place la marche pour l’autisme qui clôture le mois de sensibilisation à l’autisme au Québec. Cette année, Autisme Montréal a mis sur pied une [...]
Precipio Takes Final Step towards Regaining Nasdaq Compliance
26/04/2019
Company announces 1-for-15 reverse stock split NEW HAVEN, Conn., April 26, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) today announced that it has implemented a 1-for-15 [...]
Novo Nordisk receives positive opinion from the European regulatory authorities for Esperoct® (turoctocog alfa pegol, N8-GP) for the treatment of haemophilia A
26/04/2019
Bagsværd, Denmark, 26 April 2019 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), adopted a positive opinion for the use of [...]
Emisphere Development Update
26/04/2019
ROSELAND, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Novo Nordisk today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for oral semaglutide, a glucagon-like [...]
Key Patent Coverage for Asklepion Pharmaceuticals’ Investigational Candidate Extended to 2036
26/04/2019
BALTIMORE, April 26, 2019 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”), a biotechnology company focused on the development of novel therapeutics for rare pediatric diseases, today [...]
European Commission Grants Conditional Marketing Authorization for Portola Pharmaceuticals’ Ondexxya™ (andexanet alfa), the First and Only Antidote for the Reversal of Factor Xa Inhibitors
26/04/2019
– Major Advance in the Treatment of European Factor Xa Inhibitor Patients Hospitalized with Life-Threatening Bleeding – – Initial Launch in Select Countries to Begin 2H 2019 – SOUTH SAN FRANCISCO, Calif., April 26, 2019 [...]
CB2 Insights to Host FY2018 Earnings Call on May 1, 2019
26/04/2019
TORONTO, April 26, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII), a leading provider of medical cannabis-focused Real World Evidence to the healthcare sector, will be hosting its fiscal year [...]
Aequus Announces Filing of Prospectus Supplement and an Update to Previously Announced Public Offering of Convertible Debenture Units
26/04/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 26, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (the “ Company ”) (TSX-V: [...]
Nexstim Plc: Managers' Transactions
26/04/2019
Company announcement, Helsinki, 26 April 2019 at 4pm (EET) Nexstim Plc: Managers' Transactions Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( "Nexstim" or "Company" ), the targeted neuromodulation company developing and marketing [...]
Chiesi Named Signature Sponsor of the Triangle March for Babies Walk & 5K Run
26/04/2019
The community is invited to walk to support the March of Dimes mission for healthy moms and babies CARY, N.C., April 26, 2019 (GLOBE NEWSWIRE) -- Chiesi is proud to return as the signature sponsor of the 2019 Triangle [...]
Wildflower Featured in CannabisNewsAudio Broadcast Examining Rare Opportunities for Profit in Cannabis Market
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Broadcast titled, “The Cannabis Bonanza Has Just [...]
Phoenix Life Announces Annual Financial Report Filings for 2017 and 2018
26/04/2019
DENVER, CO, April 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, the “Company”), an international adaptive healthcare solutions company, today [...]
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
26/04/2019
European Commission Approval Anticipated Within 90 Days NEWPORT BEACH, Calif., April 26, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on [...]
Akari Therapeutics Announces Expanded Ophthalmology Program Based on Positive Emerging Data on LTB4-C5 Dual Action in Surface and Back of the Eye Diseases
26/04/2019
In an experimental back of the eye, autoimmune uveitis (EAU) model to be reported in a poster presentation at ARVO 2019, nomacopan (Coversin) and its long acting variants administered intravitreally, reported: ○ [...]
miRagen Announces New Clinical Data for Cobomarsen in ATLL Patients at the 19th Annual HTLV Congress in Lima, Peru
26/04/2019
Continued evidence of disease stabilization observed in ATLL patients treated with cobomarsen for up to 16 months Cobomarsen allowed for rapid bone marrow recovery following chemotherapy In most patients, biomarkers [...]
111 to Announce First Quarter 2019 Unaudited Financial Results on May 16, 2019
26/04/2019
SHANGHAI, China, April 26, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its [...]
Annual Report 2018 Active Biotech AB (publ)
26/04/2019
PRESS RELEASE Active Biotech's Annual Report 2018 is now available for download at www.activebiotech.com . The Annual Report will only be digitally distributed. The English version will be available within short. [...]
Novo Nordisk files for EU regulatory approval of oral semaglutide for the treatment of type 2 diabetes
26/04/2019
Bagsværd, Denmark, 26 April 2019 - Novo Nordisk today announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for oral semaglutide, a glucagon-like peptide-1 (GLP-1 [...]
Vistin Pharma ASA: Annual Report 2018
26/04/2019
Oslo, 26 April 2019 Please find attached the Annual Report for 2018 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year results presented on 19 February [...]

Pages